1. Home
  2. KZIA vs GLBZ Comparison

KZIA vs GLBZ Comparison

Compare KZIA & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • GLBZ
  • Stock Information
  • Founded
  • KZIA 1994
  • GLBZ 1949
  • Country
  • KZIA Australia
  • GLBZ United States
  • Employees
  • KZIA N/A
  • GLBZ N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • GLBZ Major Banks
  • Sector
  • KZIA Health Care
  • GLBZ Finance
  • Exchange
  • KZIA Nasdaq
  • GLBZ Nasdaq
  • Market Cap
  • KZIA 11.7M
  • GLBZ 13.5M
  • IPO Year
  • KZIA 1999
  • GLBZ N/A
  • Fundamental
  • Price
  • KZIA $7.56
  • GLBZ $4.60
  • Analyst Decision
  • KZIA Strong Buy
  • GLBZ
  • Analyst Count
  • KZIA 3
  • GLBZ 0
  • Target Price
  • KZIA $16.00
  • GLBZ N/A
  • AVG Volume (30 Days)
  • KZIA 72.8K
  • GLBZ 6.2K
  • Earning Date
  • KZIA 12-26-2025
  • GLBZ 10-31-2025
  • Dividend Yield
  • KZIA N/A
  • GLBZ N/A
  • EPS Growth
  • KZIA N/A
  • GLBZ N/A
  • EPS
  • KZIA N/A
  • GLBZ 0.01
  • Revenue
  • KZIA $1,246,312.00
  • GLBZ $12,771,000.00
  • Revenue This Year
  • KZIA N/A
  • GLBZ N/A
  • Revenue Next Year
  • KZIA N/A
  • GLBZ N/A
  • P/E Ratio
  • KZIA N/A
  • GLBZ $503.16
  • Revenue Growth
  • KZIA N/A
  • GLBZ 13.82
  • 52 Week Low
  • KZIA $2.86
  • GLBZ $3.89
  • 52 Week High
  • KZIA $34.40
  • GLBZ $6.99
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 54.09
  • GLBZ 44.54
  • Support Level
  • KZIA $7.18
  • GLBZ $4.51
  • Resistance Level
  • KZIA $7.99
  • GLBZ $4.60
  • Average True Range (ATR)
  • KZIA 0.46
  • GLBZ 0.15
  • MACD
  • KZIA 0.03
  • GLBZ -0.02
  • Stochastic Oscillator
  • KZIA 72.19
  • GLBZ 30.62

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About GLBZ Glen Burnie Bancorp

Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.

Share on Social Networks: